In the EMPA-REG study, empagliflozin significantly reduced the risk for the composite renal outcome, which included doubling of serum creatinine, progression of macroalbuminuria, initiation of renal replacement therapy, or renal death ( Subsequent studies, such as CREDENCE, DAPA-CKD, and EMPA-KIDNEY, were specifically designed to investigate the renoprotective effects of SGLT-2i
Anlisis exploratorios de estos estudios sugieren que la reduccin de la inflamacin vascular podra contribuir a estos beneficios, aunque estos estudios no fueron diseados especficamente para evaluar la inflamacin como resultado primario
I have GI problems and wonder if I should avoid turmeric and curcumin
To view or add a comment, sign in Good piece from BenefitsPRO this week useful framing for the conversation with clients who feel like they're doing everything right and still getting hammered at renewal
Airport security and injection supplies Traveling with injectable medications through airport security requires minimal preparation but causes maximum anxiety for first-timers